Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
27,691,200
-
Total 13F shares
-
9,435,050
-
Share change
-
+41,313
-
Total reported value
-
$77,373,042
-
Price per share
-
$8.20
-
Number of holders
-
45
-
Value change
-
-$276,921
-
Number of buys
-
20
-
Number of sells
-
12
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) as of Q3 2018
As of 30 Sep 2018 FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) had 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 9,435,050 shares of stock of the company.
Largest 10 holders included Southpoint Capital Advisors LP, venBio Select Advisor LLC, Opaleye Management Inc., 683 Capital Management, LLC, EVENTIDE ASSET MANAGEMENT, LLC, BlackRock Inc., PUTNAM INVESTMENTS LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, STATE STREET CORP, and NORTHERN TRUST CORP.
This table shows 45 institutional shareholders of the security as of 30 Sep 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.